Takeda Pharmaceutical (TAK) Price to Sales (2018 - 2026)
Takeda Pharmaceutical's Price to Sales came in at 0.05 for the quarter ended Jun 30, 2026, up 2.9% from 0.05 a year earlier but down 13.5% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Price to Sales (2018 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Takeda Pharmaceutical's Price to Sales was 0.09, up 25.2% from the prior year.
- Going back by year, Price to Sales was 0.07 in the year ended Mar 31, 2025 (+5.8%), 0.07 in the year ended Mar 31, 2024 (-15.0%), 0.08 in the year ended Mar 31, 2023 (+22.7%) and 0.06 in the year ended Mar 31, 2022 (-25.3%).
- The five-year range for quarterly Price to Sales is 0.04 (the quarter ended Dec 31, 2024) to 0.08 (the quarter ended Mar 31, 2023).
- Year-over-year, Price to Sales has increased for six consecutive quarters, with growth averaging 6.5% over the last eight quarters.
- The fastest year-over-year change in Price to Sales over five years came in the quarter ended Mar 31, 2026 (growth of 24.0%), and the weakest in the quarter ended Jun 30, 2024 (a decline of 44.1%).
- Business Quant data shows TAK's Price to Sales at 0.06 (quarter ended Mar 31, 2026), 0.05 (quarter ended Dec 31, 2025) and 0.05 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.05 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.06 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2021 | 0.09 |
API Access
Takeda Pharmaceutical Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();